268 drugs or purchased by the second batch

According to the consensus evaluation, there are three drugs in 20; 4 billion market, the first drug has been evaluated ▍ Cefalexin capsule has been evaluated On June 11, 2015, Shanghai Pharmaceutical Group Co., Ltd issued a notice Its holding subsidiary, Shanghai Fuda Pharmaceutical Co., Ltd., received the approval document for supplementary application of Cefalexin capsule (0.125g) issued by the State Food and drug administration The drug passed the consistency evaluation of quality and efficacy of generic drugs Cefalexin capsule is an old drug developed by GSK and Eli Lilly It was first listed in the UK in 1969 At present, the main manufacturers of the drug in China are Shanghai Modern Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Pharmaceutical General Factory, Fuda pharmaceutical, etc According to iqvia1 database, the hospital purchase amount of the drug in 2018 was 14.62 million yuan ▍ there are three companies in total For Cefalexin Capsules, the number of clinics and pharmacies purchased by Kelun, Luoxin and Shanghai Fuda should exceed that of hospitals After the evaluation of Fuda pharmaceutical, there are three companies in total On April 12, 2019, Hunan Keren Cefalexin capsule (0.125g, 0.25g, 0.5g) passed the consistency evaluation; on June 4, the official website of Luoxin pharmaceutical industry released the news that Cefalexin capsule passed the consistency evaluation successfully According to the data of minenet, in 2017, the top 20 brand pattern of Cefalexin capsule in China's public medical institutions is as follows: ▍ there are three enterprises with 20 drugs, including Cefalexin capsule, which have passed the consistency evaluation, reaching (more than) three enterprises According to the incomplete statistics of cypress blue, up to now, there have been 268 product conformity evaluations involving 120 pharmaceutical enterprises (the number passed by branches is not included in the head office) Among them, Zhejiang Huahai Pharmaceutical Co., Ltd has 20 product specifications passing the consistency evaluation, Fosun Group ranks second with one product specification difference, with 19 product specifications passing the evaluation, Kelun Pharmaceutical Co., Ltd and Qilu Pharmaceutical Co., Ltd have 16 product specifications passing the evaluation, ranking third (the number of branch companies passing the evaluation is included in the head office) ▍ 4 billion market, and now the first ever evaluated In fact, there are also the first ever evaluated drugs in a large field recently Recently, Haizheng Pharmaceutical Co., Ltd announced that the simvastatin tablets (10mg, 20mg, 40mg) of Hanhui pharmaceutical, a holding subsidiary, passed the quality and efficacy consistency evaluation of generic drugs, making the company the first one to have ever been evaluated According to the data of minenet, in 2018, the market size of terminal statins in public hospitals in key provinces and cities has exceeded 4.3 billion yuan, and so far, there are four products that have passed the consistency evaluation, including rosuvastatin calcium tablets, atorvastatin calcium tablets, pivastatin calcium tablets and simvastatin tablets Status of statins that have passed or are deemed to have passed the consistency evaluation: (source: minenet) and supplementary application for consistency evaluation of statins that are under review and approval: (source: minenet) According to the current national policy, only after passing the evaluation can they be qualified to participate in the volume procurement The second batch of volume procurement is expected to be implemented this year, and the competition is increasingly fierce.